Ulcerative Colitis (UC) - Epidemiology Forecast to 2032

January 2022 | 60 pages | ID: U90C43F80E6EN
DelveInsight

Abstracts

This report can be delivered to the clients within 5-7 Business Days

DelveInsight's 'Ulcerative Colitis (UC) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Ulcerative Colitis (UC) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2019-2032

Ulcerative Colitis (UC) Understanding

The DelveInsight Ulcerative Colitis (UC) epidemiology report gives a thorough understanding of the Ulcerative Colitis (UC) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Ulcerative Colitis (UC) in the US, Europe, and Japan. The report covers the detailed information of the Ulcerative Colitis (UC) epidemiology scenario in seven major countries (US, EU5, and Japan).

Ulcerative Colitis (UC) Epidemiology Perspective by DelveInsight

The Ulcerative Colitis (UC) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Ulcerative Colitis (UC) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Ulcerative Colitis (UC) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Ulcerative Colitis (UC) Detailed Epidemiology Segmentation

The Ulcerative Colitis (UC) epidemiology covered in the report provides historical as well as forecasted Ulcerative Colitis (UC) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

The DelveInsight Ulcerative Colitis (UC) report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report

• The Ulcerative Colitis (UC) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The Ulcerative Colitis (UC) Epidemiology Report and Model provide an overview of the global trends of Ulcerative Colitis (UC) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight into the historical and forecasted patient pool of Ulcerative Colitis (UC) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps recognize the growth opportunities in the 7MM for the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Ulcerative Colitis (UC)
• The report provides the segmentation of the Ulcerative Colitis (UC) epidemiology

Report Highlights

• 11-year Forecast of Ulcerative Colitis (UC) epidemiology
• 7MM Coverage
• Prevalent and Diagnosed Cases of Ulcerative Colitis (UC)
• Cases of Ulcerative Colitis (UC) by Mutation Types
• Ulcerative Colitis (UC) Cases associated with Clinical Manifestations

KOL views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Ulcerative Colitis (UC)?
• What are the key findings pertaining to the Ulcerative Colitis (UC) epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2019-2032)?
• What would be the total number of patients of Ulcerative Colitis (UC) across the 7MM during the forecast period (2019-2032)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019-2032)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?
• What is the disease risk, burden and unmet needs of Ulcerative Colitis (UC)?
• What are the currently available treatments of Ulcerative Colitis (UC)?

Reasons to buy

The Ulcerative Colitis (UC) Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Ulcerative Colitis (UC) market
• Quantify patient populations in the global Ulcerative Colitis (UC) market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Ulcerative Colitis (UC) therapeutics in each of the markets covered
• Understand the magnitude of Ulcerative Colitis (UC) population by its epidemiology
• The Ulcerative Colitis (UC) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Contents

1. KEY INSIGHTS

2. EXECUTIVE SUMMARY OF ULCERATIVE COLITIS (UC)

3. ULCERATIVE COLITIS (UC): DISEASE BACKGROUND AND OVERVIEW

3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis

4. PATIENT JOURNEY

5. EPIDEMIOLOGY AND PATIENT POPULATION

5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
  5.3.1. Ulcerative Colitis (UC) Epidemiology Scenario in the 7MM (2019- 2032)
5.4. United States Epidemiology
  5.4.1. Ulcerative Colitis (UC) Epidemiology Scenario in the United States (2019- 2032)
5.5. EU-5 Country-wise Epidemiology
  5.5.1. Germany Epidemiology
    5.5.1.1. Ulcerative Colitis (UC) Epidemiology Scenario in Germany (2019- 2032)
  5.5.2. France Epidemiology
    5.5.2.1. Ulcerative Colitis (UC) Epidemiology Scenario in France (2019- 2032)
  5.5.3. Italy Epidemiology
    5.5.3.1. Ulcerative Colitis (UC) Epidemiology Scenario in Italy (2019- 2032)
  5.5.4. Spain Epidemiology
    5.5.4.1. Ulcerative Colitis (UC) Epidemiology Scenario in Spain (2019- 2032)
  5.5.5. United Kingdom Epidemiology
    5.5.5.1. Ulcerative Colitis (UC) Epidemiology Scenario in the United Kingdom (2019-2032)
5.6. Japan Epidemiology
  5.6.1. Ulcerative Colitis (UC) Epidemiology Scenario in Japan (2019- 2032)

6. TREATMENT ALGORITHM, CURRENT TREATMENT, AND MEDICAL PRACTICES

6.1. Ulcerative Colitis (UC) Treatment and Management
6.2. Ulcerative Colitis (UC) Treatment Algorithm

7. KOL VIEWS

8. UNMET NEEDS

9. APPENDIX

9.1. Bibliography
9.2. Report Methodology

10. DELVEINSIGHT CAPABILITIES

11. DISCLAIMER

12. ABOUT DELVEINSIGHT

*The table of contents is not exhaustive; will be provided in the final report

List Of Tables

LIST OF TABLES

List of Table:
Table 1: Ulcerative Colitis (UC) Epidemiology in 7MM (2019-2032)
Table 2: Ulcerative Colitis (UC) Diagnosed and Treatable Cases in 7MM (2019-2032)
Table 3: Ulcerative Colitis (UC) Epidemiology in the United States (2019-2032)
Table 4: Ulcerative Colitis (UC) Diagnosed and Treatable Cases in the United States (2019-2032)
Table 5: Ulcerative Colitis (UC) Epidemiology in Germany (2019-2032)
Table 6: Ulcerative Colitis (UC) Diagnosed and Treatable Cases in Germany (2019-2032)
Table 7: Ulcerative Colitis (UC) Epidemiology in France (2019-2032)
Table 8: Ulcerative Colitis (UC) Diagnosed and Treatable Cases in France (2019-2032)
Table 9: Ulcerative Colitis (UC) Epidemiology in Italy (2019-2032)
Table 10: Ulcerative Colitis (UC) Diagnosed and Treatable Cases in Italy (2019-2032)
Table 11: Ulcerative Colitis (UC) Epidemiology in Spain (2019-2032)
Table 12: Ulcerative Colitis (UC) Diagnosed and Treatable Cases in Spain (2019-2032)
Table 13: Ulcerative Colitis (UC) Epidemiology in the United Kingdom (2019-2032)
Table 14: Ulcerative Colitis (UC) Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Table 15: Ulcerative Colitis (UC) Epidemiology in Japan (2019-2032)
Table 16: Ulcerative Colitis (UC) Diagnosed and Treatable Cases in Japan (2019-2032)

List Of Figures

LIST OF FIGURES

List of Figures
Figure 1 Ulcerative Colitis (UC) Epidemiology in 7MM (2019-2032)
Figure 2 Ulcerative Colitis (UC) Diagnosed and Treatable Cases in 7MM (2019-2032)
Figure 3 Ulcerative Colitis (UC) Epidemiology in the United States (2019-2032)
Figure 4 Ulcerative Colitis (UC) Diagnosed and Treatable Cases in the United States (2019-2032)
Figure 5 Ulcerative Colitis (UC) Epidemiology in Germany (2019-2032)
Figure 6 Ulcerative Colitis (UC) Diagnosed and Treatable Cases in Germany (2019-2032)
Figure 7 Ulcerative Colitis (UC) Epidemiology in France (2019-2032)
Figure 8 Ulcerative Colitis (UC) Diagnosed and Treatable Cases in France (2019-2032)
Figure 9 Ulcerative Colitis (UC) Epidemiology in Italy (2019-2032)
Figure 10 Ulcerative Colitis (UC) Diagnosed and Treatable Cases in Italy (2019-2032)
Figure 11 Ulcerative Colitis (UC) Epidemiology in Spain (2019-2032)
Figure 12 Ulcerative Colitis (UC) Diagnosed and Treatable Cases in Spain (2019-2032)
Figure 13 Ulcerative Colitis (UC) Epidemiology in the United Kingdom (2019-2032)
Figure 14 Ulcerative Colitis (UC) Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Figure 15 Ulcerative Colitis (UC) Epidemiology in Japan (2019-2032)
Figure 16 Ulcerative Colitis (UC) Diagnosed and Treatable Cases in Japan (2019-2032)
*The table of contents is not exhaustive; will be provided in the final report